However, studies on gastric cancer, leukemic, and glioblastoma cell lines found that CDKN3 overexpression has been associated with the inhibition of cell proliferation and metastasis promotion.[26–28] In contrast, CDKN3 is a tumor suppressor gene and found to be downregulated in brain tumors.[29]. Here, CDKN3 is linked to glioblastoma.